We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kronos Worldwide's (KRO) Stock Up 25% in 6 Months: Here's Why
Read MoreHide Full Article
Kronos Worldwide, Inc.’s (KRO - Free Report) shares have popped 25% over the past six months. The company has outperformed its industry’s decline of 6.1% over the same time frame. It has also topped the S&P 500’s roughly 16.5% decline over the same period.
Let’s take a look into the factors that are driving this a Zacks Rank #1 (Strong Buy) stock.
Image Source: Zacks Investment Research
What’s Favoring KRO?
Forecast-topping earnings performance in the first quarter and upbeat prospects have contributed to the run-up in the company's shares. Kronos Worldwide’s first-quarter earnings of 50 cents per share topped the Zacks Consensus Estimate of 28 cents. It benefited from higher income from operations resulting from increased average titanium dioxide (TiO2) selling prices. Higher TiO2 selling prices and volumes also led to a 21% rise in the company’s top line.
The company, on its first-quarter call, said that it expects global demand for consumer products to remain strong through the balance of 2022. Based on strong demand, TiO2 selling prices are projected to increase through the balance of the year. Kronos Worldwide also expects its sales and income from operations for 2022 to be higher on a year-over-year basis.
Kronos Worldwide is expected to benefit from higher demand for TiO2. Higher demand in European and North American markets are likely to drive its TiO2 sales volumes. New product development, a solid customer base and effective marketing strategies are also working in the company’s favor.
The company is also gaining from higher selling prices. Its average TiO2 selling prices rose 7% on a year-over-year basis in the first quarter. The company is expected to continue to benefit from higher TiO2 selling prices in the second quarter of 2022 on strong consumer demand.
Earnings estimates for Kronos Worldwide have also been going up over the past two months, reflecting analysts’ optimism. The Zacks Consensus Estimate for 2022 has increased around 60.9%. The consensus estimate for the second quarter of 2022 has also been revised 54.5% upward over the same time frame.
Other top-ranked stocks worth considering in the basic materials space include Nutrien Ltd. (NTR - Free Report) , Albemarle Corporation (ALB - Free Report) and Cabot Corporation (CBT - Free Report) .
Nutrien, sporting a Zacks Rank #1, has an expected earnings growth rate of 175.4% for the current year. The Zacks Consensus Estimate for NTR's current-year earnings has been revised 31% upward over the last 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.
Nutrien beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missed once. It has a trailing four-quarter earnings surprise of roughly 5.8%, on average. NTR has rallied roughly 34% in a year.
Albemarle has a projected earnings growth rate of 212.6% for the current year. The Zacks Consensus Estimate for ALB’s current-year earnings has been revised 106% upward in the past 60 days.
Albemarle’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 22.5%. ALB has rallied roughly 34% in a year. The company flaunts a Zacks Rank #1.
Cabot, currently carrying a Zacks Rank #2 (Buy), has an expected earnings growth rate of 21.5% for the current fiscal year. The Zacks Consensus Estimate for CBT's earnings for the current fiscal has been revised 5.2% upward in the past 60 days.
Cabot’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 16.2%. CBT has gained around 12% over a year.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Kronos Worldwide's (KRO) Stock Up 25% in 6 Months: Here's Why
Kronos Worldwide, Inc.’s (KRO - Free Report) shares have popped 25% over the past six months. The company has outperformed its industry’s decline of 6.1% over the same time frame. It has also topped the S&P 500’s roughly 16.5% decline over the same period.
Let’s take a look into the factors that are driving this a Zacks Rank #1 (Strong Buy) stock.
Image Source: Zacks Investment Research
What’s Favoring KRO?
Forecast-topping earnings performance in the first quarter and upbeat prospects have contributed to the run-up in the company's shares. Kronos Worldwide’s first-quarter earnings of 50 cents per share topped the Zacks Consensus Estimate of 28 cents. It benefited from higher income from operations resulting from increased average titanium dioxide (TiO2) selling prices. Higher TiO2 selling prices and volumes also led to a 21% rise in the company’s top line.
The company, on its first-quarter call, said that it expects global demand for consumer products to remain strong through the balance of 2022. Based on strong demand, TiO2 selling prices are projected to increase through the balance of the year. Kronos Worldwide also expects its sales and income from operations for 2022 to be higher on a year-over-year basis.
Kronos Worldwide is expected to benefit from higher demand for TiO2. Higher demand in European and North American markets are likely to drive its TiO2 sales volumes. New product development, a solid customer base and effective marketing strategies are also working in the company’s favor.
The company is also gaining from higher selling prices. Its average TiO2 selling prices rose 7% on a year-over-year basis in the first quarter. The company is expected to continue to benefit from higher TiO2 selling prices in the second quarter of 2022 on strong consumer demand.
Earnings estimates for Kronos Worldwide have also been going up over the past two months, reflecting analysts’ optimism. The Zacks Consensus Estimate for 2022 has increased around 60.9%. The consensus estimate for the second quarter of 2022 has also been revised 54.5% upward over the same time frame.
Kronos Worldwide Inc Price and Consensus
Kronos Worldwide Inc price-consensus-chart | Kronos Worldwide Inc Quote
Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include Nutrien Ltd. (NTR - Free Report) , Albemarle Corporation (ALB - Free Report) and Cabot Corporation (CBT - Free Report) .
Nutrien, sporting a Zacks Rank #1, has an expected earnings growth rate of 175.4% for the current year. The Zacks Consensus Estimate for NTR's current-year earnings has been revised 31% upward over the last 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.
Nutrien beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missed once. It has a trailing four-quarter earnings surprise of roughly 5.8%, on average. NTR has rallied roughly 34% in a year.
Albemarle has a projected earnings growth rate of 212.6% for the current year. The Zacks Consensus Estimate for ALB’s current-year earnings has been revised 106% upward in the past 60 days.
Albemarle’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 22.5%. ALB has rallied roughly 34% in a year. The company flaunts a Zacks Rank #1.
Cabot, currently carrying a Zacks Rank #2 (Buy), has an expected earnings growth rate of 21.5% for the current fiscal year. The Zacks Consensus Estimate for CBT's earnings for the current fiscal has been revised 5.2% upward in the past 60 days.
Cabot’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 16.2%. CBT has gained around 12% over a year.